Zobrazeno 1 - 10
of 764
pro vyhledávání: '"Shepherd, Fa"'
Autor:
Wu, YL, Tsuboi, M, He, J, John, T, Grohe, C, Majem, M, Goldman, JW, Laktionov, K, Kim, SW, Kato, T, Vu, HV, Lu, S, Lee, KY, Akewanlop, C, Yu, CJ, de Marinis, F, Bonanno, L, Domine, M, Shepherd, FA, Zeng, LM, Hodge, R, Atasoy, A, Rukazenkov, Y, Herbst, RS, ADAURA Investigators
Publikováno v:
NEW ENGLAND JOURNAL OF MEDICINE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
BackgroundOsimertinib is standard-of-care therapy for previously untreated epidermal growth factor receptor (EGFR) mutation-positive advanced non-small-cell lung cancer (NSCLC). The efficacy and safety of osimertinib as adjuvant therapy are unknown.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::33ef27ca238c74444dfa6bf777d3afd2
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1302
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1302
Publikováno v:
In American Journal of Transplantation April 2007 7(4):941-948
Autor:
GRIDELLI C, ARDIZZONI A, HANNA N, HEYMACH JV, PERRONE F, ROSELL, R, SHEPHERD FA, THATCHER N, VANSTEENKISTE J, DE PETRIS L, DI MAIO M, DE MARINIS, CIARDIELLO, Fortunato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3977::8de9a2eb529c12b0f200328bddeaacd5
http://hdl.handle.net/11591/166355
http://hdl.handle.net/11591/166355
Autor:
GRIDELLI C, ARDIZZONI A, HANNA N, HEYMACH JV, PERRONE F, ROSELL R, SHEPHERD FA, THATCHER N, VANSTEENKISTE J, DE PETRIS L, DI MAIO M, DE MARINIS F., CIARDIELLO, Fortunato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3977::6129f88df93fce9bc9062f3e0f090dfb
http://hdl.handle.net/11591/186567
http://hdl.handle.net/11591/186567
Publikováno v:
Huang, CH; Shepherd, FA; & Kelly, K. (2012). Chemotherapy for small cell lung cancer. In Principles and Practice of Lung Cancer: The Official Reference Text of the International Association for the Study of Lung Cancer (IASLC): Fourth Edition. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/54b7t49f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::5293db70c4a1556ebbd4dc38f1ed18f4
http://www.escholarship.org/uc/item/54b7t49f
http://www.escholarship.org/uc/item/54b7t49f
Autor:
Vallières, E, Shepherd, Fa, Crowley, J, Van Houtte, P, Postmus, Pe, Carney, D, Chansky, K, Shaikh, Z, Goldstraw, P, International Association for the Study of Lung Cancer International Staging Committee, Participating, Institutions, Scagliotti, Giorgio Vittorio, Borasio, Piero
Publikováno v:
Vallieres, E, Shepherd, F A, Crowley, J J, Van Houtte, P, Postmus, P E, Carney, D, Chansky, K, Shaikh, Z & Goldstraw, P 2009, ' The IASLC Lung Cancer Staging Project Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer ', Journal of Thoracic Oncology, vol. 4, no. 9, pp. 1049-1059 . https://doi.org/10.1097/JTO.0b013e3181b27799
Journal of Thoracic Oncology, 4(9), 1049-1059. International Association for the Study of Lung Cancer
Journal of Thoracic Oncology, 4(9), 1049-1059. International Association for the Study of Lung Cancer
Introduction For more than 50 years, small cell lung cancer (SCLC) has been staged mainly as either limited or extensive stage disease. Small published series of resected SCLC have suggested that the tumor, node, metastases (TNM) pathologic staging c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f5d36f3f1c848548be8bbab436d7950
https://research.vumc.nl/en/publications/af5c8362-6aa9-452c-a0f0-5dfc8e910402
https://research.vumc.nl/en/publications/af5c8362-6aa9-452c-a0f0-5dfc8e910402
Autor:
Pignon, Jp, Tribodet, H, Scagliotti, Giorgio Vittorio, Douillard, Jy, Shepherd, Fa, Stephens, Rj, Dunant, A, Torri, V, Rosell, R, Seymour, L, Spiro, Sg, Rolland, E, Fossati, R, Aubert, D, Ding, K, Waller, D, Le Chevalier, T, LACE Collaborative Group
Purpose Several recent trials have shown a significant overall survival (OS) benefit from postoperative cisplatin-based chemotherapy in patients with non–small-cell lung cancer (NSCLC). The aim of the Lung Adjuvant Cisplatin Evaluation was to ident
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bcc2dc60ad9bafc025064c6a0891b53
http://hdl.handle.net/2318/48055
http://hdl.handle.net/2318/48055
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.